Lisa Wiesmüller Selected Research

Mitochondrial DNA (mtDNA)

1/2022

Polymerase ζ Is Involved in Mitochondrial DNA Maintenance Processes in Concert with APE1 Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa Wiesmüller Research Topics

Disease

31	Neoplasms (Cancer) 04/2022 - 07/2002
10	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2007
6	Genomic Instability 01/2021 - 04/2010
5	Leukemia 01/2021 - 01/2015
5	Carcinogenesis 10/2017 - 04/2008
5	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017 - 02/2008
3	Carcinoma (Carcinomatosis) 04/2022 - 08/2008
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
2	Adenocarcinoma 01/2021 - 10/2017
2	Neoplasm Metastasis (Metastasis) 04/2020 - 08/2019
2	Circulating Neoplastic Cells 04/2020 - 08/2019
2	Chromosomal Instability (Chromosome Stability) 11/2017 - 01/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2017 - 05/2014
2	Chromosome Breakage 01/2017 - 01/2015
1	AIDS-Related Complex (ARC) 01/2022
1	familial Prostate cancer 01/2021
1	Aneuploidy (Aneuploid) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Microcephaly 01/2019
1	Hyperpigmentation 01/2019
1	Amenorrhea 01/2017
1	Primary Ovarian Insufficiency 01/2017
1	Lung Neoplasms (Lung Cancer) 07/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2015
1	Squamous Cell Carcinoma of Head and Neck 04/2015
1	Fanconi Anemia (Fanconi's Anemia) 04/2015
1	Infections 01/2015
1	Familial Breast Cancer 03/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011
1	Premature Aging 04/2010
1	Nijmegen Breakage Syndrome 04/2010
1	Glioblastoma (Glioblastoma Multiforme) 10/2009

Drug/Important Bio-Agent (IBA)

22	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2002
17	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021 - 04/2007
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2002
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 08/2008
5	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2022 - 10/2014
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
3	PlatinumIBA 01/2021 - 07/2016
3	Phosphotransferases (Kinase)IBA 10/2017 - 11/2011
2	olaparibIBA 04/2022 - 01/2021
2	DDTIBA 10/2021 - 12/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2021
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 01/2017
2	Biological ProductsIBA 01/2020 - 01/2013
2	ChromatinIBA 01/2017 - 04/2008
2	Small Interfering RNA (siRNA)IBA 03/2015 - 03/2008
2	CarcinogensIBA 05/2014 - 02/2008
2	EnzymesIBA 04/2007 - 08/2002
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Peptide LibraryIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	enhanced green fluorescent proteinIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 04/2020
1	eribulin FDA Link 04/2020
1	Hormones (Hormone)IBA 04/2020
1	eprenetapoptIBA 01/2020
1	ParaffinIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	GonadotropinsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 07/2016
1	NucleotidesIBA 07/2016
1	proteasome maturation proteinIBA 03/2016
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2016
1	UbiquitinIBA 01/2016
1	Ligases (Synthetase)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2016
1	Codon (Codons)IBA 10/2015
1	Lamin Type B (Lamin B)IBA 03/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2015
1	AnthracyclinesIBA 01/2015
1	ORALIT (ORS)IBA 05/2012
1	Protein CIBA 02/2012
1	A-Form DNA (A-DNA)IBA 09/2011
1	Oncogene Proteins (Oncogene Protein)IBA 01/2011
1	ChemokinesIBA 04/2010
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2010
1	Sirtuin 1IBA 04/2010
1	NF-KappaB Inhibitor alphaIBA 10/2009
1	Intercalating AgentsIBA 10/2009
1	NF-kappa B (NF-kB)IBA 10/2009
1	Cyclin A1IBA 09/2008
1	Caffeine (No Doz)FDA LinkGeneric 03/2008

Therapy/Procedure

15	Therapeutics 01/2021 - 08/2008
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2015
1	Induction Chemotherapy 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Adjuvant Chemotherapy 11/2016
1	Radiotherapy 01/2015
1	Transplantation 01/2015